Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Thumbnail

Private equity-backed cardiology group acquires ‘world-class' practice with team of 23 cardiologists

This latest acquisition continues what has been a busy year for Cardiovascular Associates of America. 

M&A mergers and acquisitions business deal

Private equity firm acquiring 'leading' teleradiology group that spans 48 states

Grovecourt Capital Partners said it hopes to fuel further expansion for Miami-based Premier Radiology Services, which was founded in 2006. 

Thumbnail

Cardiologist accused of date rape by 15 women could face life in prison, judge says

The cardiologist's bond has been set at $5 million. He will appear in court next on June 22 for a preliminary hearing.

FDA warns healthcare providers about recalled CPB, ECMO devices

Multiple medical devices used during cardiopulmonary bypass and extracorporeal membrane oxygenation procedures have been voluntarily recalled due to issues with their packaging.

Malissa Wood, MD. explains why Mass General created a program to combat racism and health equity.

Why health equity is important in cardiology

Malissa Wood, MD, associate chief of cardiology for diversity and equity at Massachusetts General Hospital, explains the role of health equity in cardiovascular care and what her health system is doing to address it. 

doctor telehealth computer screen

Healthcare entities offering employees direct-to-consumer telemedicine could cut costs nearly 25%

“This research shows the clear financial benefits when hospitals and health systems offer telemedicine services directly to their own employees."

Thumbnail

How the Mark Cuban prescription drug playbook could save taxpayers billions

A new analysis reveals that insurers could put between $228 million and $2.15 billion back in taxpayers’ pockets by purchasing a series of generic oncology medications at the same prices obtained by the Mark Cuban Cost Plus Drug Company.

artificial intelligence industry

Industry Watcher’s Digest

Buzzworthy developments of the past few days.